Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Camidge

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

PL02.03 Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK+ NSCLC: First Report of a Phase 3 Trial (ALTA-1L)

Journal of Thoracic Oncology

Respiratory Medicine

English

OA12.06 Mutational Landscape of BRAF V600E Positive Lung Cancer Patients Following BRAF Directed Therapy Failure

Journal of Thoracic Oncology

Respiratory Medicine

English

MA02.01 ROS1 Gene Rearrangements Are Associated With an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events

Journal of Thoracic Oncology

Respiratory Medicine

English

MS06.04 Systemic Therapy for Oligomets: Before, During, or After Local Therapies?

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-62 the Third Generation Irreversible EGFR Inhibitor HS-10296 in Advanced Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-78 the Incidence of Brain Metastases in ROS1-Rearranged Non-Small Cell Lung Cancer at Diagnosis and Following Progression on Crizotinib

Journal of Thoracic Oncology

Respiratory Medicine

English